recurrent primary amyloidosis

Showing 1 - 3 of 3

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Amorphous, Eosinophilic, and Acellular Deposit, Constipation, Diarrhea Trial in United States (Isatuximab, Laboratory Biomarker

Active, not recruiting
  • Amorphous, Eosinophilic, and Acellular Deposit
  • +12 more
  • Isatuximab
  • Laboratory Biomarker Analysis
  • Anchorage, Alaska
  • +344 more
Aug 22, 2022

Recurrent Primary Amyloidosis Trial in United States (drug, biological, other)

Active, not recruiting
  • Recurrent Primary Amyloidosis
  • Duarte, California
  • +4 more
Mar 10, 2021

Newly Diagnosed Primary Amyloidosis, Recurrent Primary Amyloidosis, Refractory Primary Amyloidosis Trial in Houston

Recruiting
  • Newly Diagnosed Primary Amyloidosis
  • +2 more
  • Daratumumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 12, 2021